Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Apolipoprotein(a) size polymorphism is associated with coronary heart disease in polygenic hypercholesterolemia.

Nutrition, metabolism, and cardiovascular diseases : NMCD - 1 Aug 2004

Emanuele E, Peros E, Minoretti P, D'Angelo A, Piccinni M N, Montagna L, Geroldi D

Abstract excerpt

BACKGROUND AND AIM: In addition to high serum cholesterol levels, various cardiovascular risk factors may be involved in the development of coronary heart disease (CHD) in hypercholesterolemic subjects. As the levels of lipoprotein(a) [Lp(a)], an important and independent cardiovascular risk factor, are high in polygenic hypercholesterolemia (PH), we investigated plasma Lp(a) levels and apolipoprotein(a) [apo(a)]...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Apolipoproteins A

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Coronary Disease

Share to Discriminant Analysis

Share to Hypercholesterolemia

Share to Lipoprotein(a)

Share to Molecular Weight

Share to Protein Isoforms

Source

Identifiers

PMID: 15553596
DOI: 10.1016/s0939-4753(04)80004-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Apolipoprotein(a) size polymorphism is associated with coronary heart disease in polygenic hypercholesterolemia.PMID 15553596Read ↗

Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary heart disease in patients with essential hypertension.Semantic proximity Read ↗

Polymorphism and peripheral levels of apolipoprotein(a) in polygenic hypercholesterolemia and combined hyperlipidemia.Semantic proximity Read ↗

Lipoprotein(a) plasma concentrations, apolipoprotein (a) polymorphism and family history of coronary heart disease in patients with essential hypertension.Semantic proximity Read ↗

[Apolipoprotein (a) polymorphism in relation to coronary heart disease in Chinese Han nationality].Semantic proximity Read ↗

Heterozygous apolipoprotein (a) status and protein expression as a risk factor for premature coronary heart disease.Semantic proximity Read ↗

Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease.Semantic proximity Read ↗

Lipoprotein(a) levels, apo(a) isoform size, and coronary heart disease risk in the Framingham Offspring StudySemantic proximity Read ↗

[Association of lipoprotein(a) and apolipoprotein(a) phenotypes with coronary and carotid atherosclerosis in CHD men].Semantic proximity Read ↗

Lipoprotein(a)Semantic proximity Read ↗

Lipoprotein(a). A genetic risk factor for premature coronary heart diseaseSemantic proximity Read ↗

Apolipoprotein(a) phenotypes are reliable biomarkers for familial aggregation of coronary heart disease.Semantic proximity Read ↗

Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.